Qumis | $2,200,000 | (Jan 22, 2025)
Zynap | $5,937,902 | (Jan 22, 2025)
Belfry | $12,000,000 | (Jan 22, 2025)
Certified by Founder
Lodge
CHARM Therapeutics
start up
United Kingdom
- London
- 09/06/2022
- Series A
- $50,000,000
Harnessing the power of deep learning on 3D molecular configurations to deliver medicines of transformational efficacy to patients.
- Industry Research Services
- Website https://charmtx.com/
- LinkedIn https://www.linkedin.com/company/charm-therapeutics/
Related People
Laksh AithaniFounder
United Kingdom -
London, England,
Passionate about drug discovery and machine learning
Gravity | $13,000,000 | (Jan 22, 2025)
LeapXpert | $20,000,000 | (Jan 22, 2025)
BPR Hub | $2,600,000 | (Jan 22, 2025)
NovoLINC | Undisclosed Amount | (Jan 22, 2025)
IntusCare | $11,500,000 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)